from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3860/-

LFCtreatmentdescriptionclass of inhibitor

-0.091

Amikacinug/mL Amikacintranslation

-0.953

Cap5-10ug/mL Capreomycintranslation

-0.221

Rox10-50 ug/mL Roxithromycintranslation

0.214

SM2-5 ug/mL Streptomycintranslation

-0.685

Tet5-10 ug/mL Tetracyclinetranslation

2.143

Rif0.2-5ug/mL Rifampicintranscription

1.138

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.096

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.536

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.418

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.793

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.363

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.327

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.236

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.429

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.715

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.883

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.361

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.827

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.199

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.730

Nigericin50 uM Nigericinrespiration

0.759

TRC10-150 ug/mL Triclosanrespiration

0.175

TRZ10-25 ug/mL Thioridazinerespiration

0.374

Valinomycin0.5-10 uM Valinomycinrespiration

0.466

ZnSO42 mM ZnSO4respiration

0.477

menadione6-10 ug/mL Menadionerespiration

0.037

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.068

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.308

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.041

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.934

NRP_1Non-replicating persistence stage 1dosRassociated

-0.159

Amp0.2mg/mL AmpicillincellWall

-0.273

Cephalexin20-100 ug/mL CephalexincellWall

-0.614

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.700

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.753

EMB10-20 ug/mL EthambutolcellWall

-0.391

Eta12-40 ug/mL EthionamidecellWall

-1.050

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.245

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.061

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.176

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.255

BZA0.12 mg/mL BenzamidearomaticAmides

0.241

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.490

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.646

H2O24 mM hydrogen peroxideDNAdamaging

0.184

Levo10 ug/mL LevofloxacinDNAdamaging

0.059

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.585

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.071

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.062

UVUV-irradiationDNAdamaging

1.527

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.196

Antimycin12.5-50 ug/mL Antimycin A?

0.325

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.179

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.333

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.623

PA8240.2-2 ug/mL PA-824?

-0.442

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.098

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.084

Verapamil50 uM Verapamil?

0.893

mercaptoethanol2 mM 2-Mercaptoethanol?

0.492

methoxatin10-20 ug/mL Methoxatin?